Skip to content Skip to navigation

Weill Cornell, New York Presbyterian Launch Individualized Medicine Hub

January 31, 2013
by Rajiv Leventhal
| Reprints

New York-based Weill Cornell Medical College and NewYork-Presbyterian Hospital have partnered to create the Institute for Precision Medicine, a new medicine research hub that will offer targeted, individualized treatment based on each patient's genetic profile.

The Institute for Precision Medicine will be led by Dr. Mark Rubin, a renowned pathologist and prostate cancer expert who uses whole genomic sequencing in his laboratory to investigate DNA mutations that lead to disease, particularly prostate cancer.

The institute's new genomic research discoveries will help develop novel, personalized medical therapies to be tested in innovative clinical trials, while also building a comprehensive biobank to improve research and patient care. "This institute will revolutionize the way we treat disease, linking cutting-edge research and next-generation sequencing in the laboratory to the patient's bedside," Rubin said in a statement. "We will use advanced technology and the collective wealth of knowledge from our clinicians, basic scientists, pathologists, molecular biologists and computational biologists to pinpoint the molecular underpinnings of disease -- information that will spur the discovery of novel treatments and therapies. It's an exciting time to be involved in precision medicine and I look forward to advancing this game-changing field of medicine."

 Rubin and his team seek to replace the traditional one-size-fits-all medicine paradigm with one that focuses on targeted, individualized patient care using a patient's own genetic profile and medical history. Physician-scientists at the institute will seek to precisely identify the genetic influencers of a patient's specific illness—such as cancer, cardiovascular disease, neurodegenerative disease and others—and use this genetic information to design a more-effective course of treatment that targets those specific contributing factors. Also, genomic analyses of tumor tissue will enable researchers to help patients with advanced disease and no current treatment options, as well as to isolate the causes of drug resistance in patients who stop responding to treatments, redirecting them to more successful therapies.

Preventive precision medicine will also be a key initiative at the institute, allowing physician-scientists to help identify a patient's risk of diseases and take necessary steps to aid in its prevention through medical treatment and/or lifestyle modification. In addition, the Institute for Precision Medicine will leverage an arsenal of innovative genomic sequencing, biobanking and bioinformatics technology to transform the existing paradigm for diagnosing and treating patients. 

 

Topics

News

CMS Looks to Increase Patient Engagement with New Models

The Centers for Medicare & and Medicaid Services (CMS) has announced two new models from the CMS Innovation Center (CMMI) that will aim to increase patient engagement in care decisions by putting more information in the hands of Medicare beneficiaries.

Medtronic, Fitbit Integrating Health and Activity Data for Diabetes Management

Fitness wearables company Fitbit, based in San Francisco, and Dublin, Ireland-based Medtronic, a medical device company, have teamed up to integrate health and activity tracking for patients living with diabetes and their physicians and care teams.

UC San Diego Health Offering EHR, iPad Access to Patients

Patients at the recently-opened Jacobs Medical Center at UC San Diego Health can be in more command with their own experience by assessing their own medical information, controlling room features and more.

Texas Medical Center, Australia Form BioBridge to Develop Health Innovation

Houston-based Texas Medical Center (TMC) and the Melbourne-based Health Informatics Society of Australia (HISA) are collaborating on a health startup exchange program.

Teladoc Hits 101K Patient Visits in November

Telehealth vendor Teladoc announced this week that it totaled 101,600 e-health patient visits in November, setting a company record.

Research of mHealth Apps Reveals Significant Gaps in Quality

An evaluation of 137 patient-facing mobile health apps revealed that few apps address the needs of the patients who could benefit the most, according to research in December’s issue of Health Affairs.